Year: 2014

Investors in the pharma/biotech sector eagerly wait for pipeline updates as they play an important role in deciding whether or not to invest in a particular company. These updates provide information on experimental drugs and at times give an insight on the commercial potential of the candidate once it is successfully developed and commercialized. Last week, NewLink Genetics Corporation ( NLNK ) and Merck ( MRK ) announced that the U.S […]

Shares of Tetraphase Pharmaceuticals, Inc. ( TTPH ) have been riding high after the company announced positive top-line data from a phase III study evaluating its experimental antibiotic, eravacycline, for the treatment of complicated intra-abdominal infection (cIAI). […]

On Dec 26, 2014, we issued an updated research report on MeadWestvaco Corporation ( MWV ). The global packaging company expects enhanced operating productivity, cost saving initiatives, increase in consumer and industrial packaging volumes and pricing to drive growth in the fourth quarter. […]

On Dec 26, 2014, we issued an updated research report on NuStar Energy, L.P. ( NS ). The San Antonio-based publicly traded partnership has reported strong results in the past three quarters and expects a year-over-year improvement in fourth-quarter earnings. […]

On Dec 27, 2014, Zacks Investment Research upgraded Fluidigm Corporation ( FLDM ) to a Zacks Rank #1 (Strong Buy). Why the Upgrade? […]

On Dec 26, 2014, we issued an updated research report on Ericsson ( ERIC ), a leading provider of communication networks, telecom services and support solutions. Ericsson enjoys a strong foothold in the Long-Term Evolution (“LTE”) technology market, with a large number of established LTE networks worldwide. The company has been benefiting from the rising demand for 4G/ LTE technologies across emerging nations like China, India and the Middle East. […]

On Dec 25, 2014, Zacks Investment Research upgraded Barclays PLC ( BCS ) to a Zacks Rank #1 (Strong Buy). Why the Upgrade? Barclays has been witnessing rising earnings estimates, driven by the successful implementation of its expense-saving initiatives […]

On Dec 26, Visa Inc. ( V ) reached a new 52-week high of $269.32 per share, driven by its expansion initiative, a solid fourth-quarter beat and a dividend hike. With about 1.2 million shares exchanging hands, the stock closed the trading session at $266.62. […]

Ventas Inc. ( VTR ), with its diversified portfolio and strategic acquisitions, is actively capitalizing on growth opportunities amid increasing healthcare spending, aging population and a rise in insured individuals in the U.S. In fact, recently, Ventas moved a step closer to its merger with American Realty Capital Healthcare Trust Inc., with the Securities and Exchange Commission (“SEC”) declaring the Form S-4 related to this merger as effective […]

On Dec 22, 2014, we issued an updated research report on BankUnited, Inc. ( BKU ). Although the company remains focused on improving its revenues, its expenses continue to escalate. […]

SAP SE ( SAP ) recently acquired the major cloud-based travel and expense management company, Concur Technologies, in order to enhance its transition to cloud business. The decision to acquire Concur comes as a strategic move on part of SAP, as the combined group will now have access to over 50 million users in the cloud, which is more than any enterprise cloud company. […]